Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I

The aim of this study was to investigate the influence of the diagnostic administration of 74 MBq I on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Retention measurements were performed using a whole-body counter in 24 patients 6 weeks after total thyroidectomy. Profile scans were performed 2, 24, 48 and 72 h after the administration of the diagnostic dose and 72 h after the administration of the ablation-therapeutic dose (4.4 GBq). The mean (±S.D.) effective half-life of the diagnostic dose in thyroid remnants was 40.3 ± 23.0 h. The uptake in the thyroid remnants of the subsequent ablation dose 72 h after administration was 30.4 ± 19.8% of that predicted from the diagnostic study. The greater reduction in uptake was associated with the longer half-life of iodine and higher uptake in the thyroid remnants at 24 h, with a longer interval between surgery and administration of the diagnostic dose and a shorter period between administration of the diagnostic and ablation doses. Our results show that a diagnostic dose of 74 MBq I markedly reduces thyroid uptake of an ablation dose of I. This should be taken into account during radiation dose planning whenever a quantitative dosimetric study is to be performed.